Representative before the EPO

Employment test 51 - 200 employees
Company dna weickmann and weickmann
operating since 1882
Headquarter in Munich and 2 offices
active in Legal Services, IP Consulting, and IP Portfolio Processing

We have observed 50 EP applications Christian Heubeck has served for within the last five+ years. (We consider all applications which have an EP A1 or A2 publication dated after May 23, 2013). Please note, that we only count EP applications, in which the name of the patent attorney is explicitly mentioned as representative. These EP applications are:

EP11746365

USE OF TERIFLUNOMIDE FOR TREATING MULTIPLE SCLEROSIS

IPC classification:
A61P 25/02, A61P 25/28, A61K 31/275, A61K 45/06
Agent:
Christian Heubeck, Weickmann & Weickmann PartmbB
Status:
GRANT OF PATENT INTENDED
EP13156104

Methods and compositions for targeted integration

IPC classification:
C12N 15/86, C12N 15/867
Applicant:
Sangamo BioSciences, Inc.
Agent:
Christian Heubeck, Weickmann & Weickmann PartmbB
Status:
PATENT GRANTED
EP11757275

ERBB3 BINDING ANTIBODY

IPC classification:
A61P 35/00, C07K 16/32, A61K 39/395
Agent:
Christian Heubeck, Weickmann & Weickmann PartmbB
Agent:
Patronus IP Ganahl Naefe GbR
Status:
PATENT GRANTED
EP12710950

PURIFICATION OF TRIPHOSPHORYLATED OLIGONUCLEOTIDES USING CAPTURE TAGS

IPC classification:
C07H 21/02
Applicant:
University of Bonn (Rheinische Friedrich-Wilhelms-Universität Bonn)
Agent:
Hendrik Wichmann, Wuesthoff & Wuesthoff Patentanwälte PartG mbB
Agent:
Christian Heubeck, Weickmann & Weickmann PartmbB
Agent:
Armin Bohmann, Kanzlei bohmann
Status:
PATENT GRANTED
EP13151840

Wheat plants having increased resistance to imidazolinone herbicides

IPC classification:
C12N 15/82, C12N 15/29, A01H 1/00, A01H 5/00
Agent:
Christian Heubeck, Weickmann & Weickmann PartmbB
Status:
EXAMINATION IN PROGRESS
EP13173978

Use of 5-fluorocytosine and its derivatives as fungicides

IPC classification:
A01N 43/54, A01N 47/24, A01P 3/00
Applicant:
Dow AgroSciences LLC
Agent:
Christian Heubeck, Weickmann & Weickmann PartmbB
Status:
APPLICATION REFUSED
EP14152800

Methods and compositions for treating trinucleotide repeat disorders

IPC classification:
A61P 25/28, C07K 14/47, C12N 15/90, A61K 38/00, A61K 38/16, A61K 48/00
Agent:
Christian Heubeck, Weickmann & Weickmann PartmbB
Status:
EXAMINATION IN PROGRESS
EP12828871

GLYCOSYLATED POLYPEPTIDE AND DRUG COMPOSITION CONTAINING SAID POLYPEPTIDE

IPC classification:
A61P 1/00, A61P 1/04, A61P 1/12, A61P 3/10, A61P 5/02, A61P 19/02, A61P 25/04, A61P 25/28, A61P 27/02, A61P 27/06, A61P 27/12, A61P 29/00, A61P 35/00, A61P 43/00, C07K 2/00, C07K 14/655, C07K 19/00, A61K 38/00, A61K 47/48
Agent:
Christian Heubeck, Weickmann & Weickmann PartmbB
Status:
GRANT OF PATENT INTENDED
EP12828271

GLYCOSYLATED POLYPEPTIDE AND DRUG COMPOSITION CONTAINING SAID POLYPEPTIDE

IPC classification:
A61P 1/00, A61P 1/04, A61P 1/12, A61P 3/10, A61P 5/02, A61P 19/02, A61P 25/04, A61P 25/28, A61P 27/02, A61P 27/06, A61P 27/12, A61P 29/00, A61P 35/00, A61P 43/00, C07K 2/00, C07K 14/655, C07K 19/00, A61K 38/00, A61K 47/48
Agent:
Christian Heubeck, Weickmann & Weickmann PartmbB
Status:
GRANT OF PATENT INTENDED
EP14163013

Methods and compositions for gene inactivation

IPC classification:
C07K 14/715, C12N 15/113
Agent:
Christian Heubeck, Weickmann & Weickmann PartmbB
Status:
GRANT OF PATENT INTENDED
EP12839684

ERYTHROPOIETIN PRODUCTION-PROMOTING AGENT

IPC classification:
A61P 7/06, A61P 13/12, A61P 43/00, A61K 31/197, A61K 31/28, A61K 33/06, A61K 33/26, A61K 33/30
Applicant:
Tohoku University
Applicant:
SBI Pharmaceuticals Co Ltd
Agent:
Christian Heubeck, Weickmann & Weickmann PartmbB
Status:
GRANT OF PATENT INTENDED
EP12839430

IMPROVING / PROPHYLACTIC AGENT FOR CHRONIC KIDNEY DISEASE

IPC classification:
A61P 13/12, A61P 43/00, A61K 31/197, A61K 31/28, A61K 33/06, A61K 33/24, A61K 33/26, A61K 33/28, A61K 33/30, A61K 33/34
Applicant:
SBI Pharmaceuticals Co Ltd
Agent:
Christian Heubeck, Weickmann & Weickmann PartmbB
Status:
GRANT OF PATENT INTENDED
EP11863061

WORK HOOD

IPC classification:
A42B 1/04, A42B 1/24
Agent:
Christian Heubeck, Weickmann & Weickmann PartmbB
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12186444

Novel RIG-I ligands and methods for producing them

IPC classification:
C07H 21/02
Applicant:
University of Bonn (Rheinische Friedrich-Wilhelms-Universität Bonn)
Agent:
Christian Heubeck, Weickmann & Weickmann PartmbB
Status:
APPLICATION REFUSED
EP11767977

METHODS FOR SEMI-SYNTHETICALLY PRODUCING HIGHLY PURE MINICIRCLE DNA VECTORS FROM PLASMIDS

IPC classification:
C12N 15/64, C12N 15/79
Agent:
Christian Heubeck, Weickmann & Weickmann PartmbB
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12854923

AGENT FOR PREVENTING AND/OR TREATING VEISALGIA

IPC classification:
A61P 3/00, A61K 31/197, A61K 31/28, A61K 33/06, A61K 33/14, A61K 33/24, A61K 33/26, A61K 33/30, A61K 33/34
Applicant:
SBI Pharmaceuticals Co Ltd
Agent:
Christian Heubeck, Weickmann & Weickmann PartmbB
Status:
PATENT GRANTED
EP14175292

TNFSF single chain molecules

IPC classification:
C07K 14/525, C07K 14/705, C12N 15/11, C12N 15/62, A61K 38/17
Applicant:
Apogenix GmbH
Applicant:
Apogenix AG
Agent:
Christian Heubeck, Weickmann & Weickmann PartmbB
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP14170013

Methods and compositions for targeted single-stranded cleavage and targeted integration

IPC classification:
C12P 21/00
Agent:
Christian Heubeck, Weickmann & Weickmann PartmbB
Status:
GRANT OF PATENT INTENDED
EP12172594

Method for the capture or removal of amyloidogenic proteins

IPC classification:
B01J 20/282, C07K 14/47, G01N 33/68
Agent:
Christian Heubeck, Weickmann & Weickmann PartmbB
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13704961

COMBINATION OF HB-EGF BINDING PROTEIN AND EGFR INHIBITOR

IPC classification:
C07K 16/22, C07K 16/28, C07K 16/30, C07K 16/40, A61K 31/517, A61K 39/395
Agent:
Christian Heubeck, Weickmann & Weickmann PartmbB
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13705987

HER3 INHIBITOR FOR MODULATING RADIOSENSITIVITY

IPC classification:
A61P 35/00, C07K 16/32, A61K 39/00
Agent:
Christian Heubeck, Weickmann & Weickmann PartmbB
Status:
EXAMINATION IN PROGRESS
EP14177478

Ruthenium and Osmium Heterocyclic Carbene Metathesis Catalysts

IPC classification:
C07F 15/00, C08F 4/00
Applicant:
Bergen Teknologioverføring AS
Agent:
Christian Heubeck, Weickmann & Weickmann PartmbB
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP13769902

HETEROCYCLIC COMPOUND

IPC classification:
A61P 1/04, A61P 17/06, A61P 19/02, A61P 25/00, A61P 37/02, A61P 43/00, C07D 401/04, C07D 401/14, C07D 403/14, C07D 405/14, C07D 409/14, C07D 413/14, A61K 31/506, A61K 31/5377, A61K 31/541
Applicant:
Takeda Pharmaceutical Company Limited
Agent:
Christian Heubeck, Weickmann & Weickmann PartmbB
Status:
EXAMINATION IN PROGRESS
EP13772589

METHODS AND SYSTEMS FOR CUSTOMIZING COCHLEAR IMPLANT STIMULATION AND APPLICATIONS OF SAME

IPC classification:
A61F 2/02, A61F 2/18, A61F 2/76
Applicant:
Vanderbilt University
Agent:
Christian Heubeck, Weickmann & Weickmann PartmbB
Status:
The patent has been granted
EP13742057

COMBINATORIC ENCODING METHODS FOR MICROARRAYS

IPC classification:
C12Q 1/68
Applicant:
National University of Singapore
Agent:
Christian Heubeck, Weickmann & Weickmann PartmbB
Status:
PATENT GRANTED
EP13793390

A MICROPARTICLE ASSEMBLY

IPC classification:
G01N 33/533, G01N 33/542
Applicant:
National University of Singapore
Agent:
Christian Heubeck, Weickmann & Weickmann PartmbB
Status:
GRANT OF PATENT INTENDED
EP13796783

METHOD FOR ASSESSING ENDOMETRIOSIS

IPC classification:
C12N 15/09, C12Q 1/68, G01N 33/48
Applicant:
Takeda Pharmaceutical Company Limited
Agent:
Christian Heubeck, Weickmann & Weickmann PartmbB
Status:
EXAMINATION IN PROGRESS
EP12739875

INDOLE DERIVATIVE AND PHARMACOLOGICALLY ACCEPTABLE SALT OF SAME

IPC classification:
A61P 13/02, A61P 13/10, A61P 43/00, C07D 209/18, C07D 401/06, C07D 401/14, C07D 403/10, C07D 405/06, C07D 405/14, C07D 409/14, C07D 413/14, C07D 417/06, C07D 419/14, A61K 31/404, A61K 31/41, A61K 31/427, A61K 31/4439, A61K 31/444, A61K 31/506, A61K 45/00
Agent:
Christian Heubeck, Weickmann & Weickmann PartmbB
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13840884

PROCESS FOR PRODUCING SOLID PARTICLES

IPC classification:
A61K 9/14, A61K 31/192
Applicant:
Takeda Pharmaceutical Company Limited
Agent:
Christian Heubeck, Weickmann & Weickmann PartmbB
Status:
EXAMINATION IN PROGRESS
EP13857593

GLYCOSYLATED LINKER, COMPOUND CONTAINING GLYCOSYLATED LINKER MOIETY AND PHYSIOLOGICALLY ACTIVE SUBSTANCE MOIETY OR SALT THEREOF, AND METHODS FOR PRODUCING SAID COMPOUND OR SALT THEREOF

IPC classification:
A61P 31/00, A61P 35/00, C07K 4/12, C08B 37/00, A61K 38/00, A61K 47/48
Agent:
Christian Heubeck, Weickmann & Weickmann PartmbB
Status:
GRANT OF PATENT INTENDED
EP13859242

SUGAR CHAIN-ATTACHED LINKER, COMPOUND CONTAINING SUGAR CHAIN-ATTACHED LINKER AND PHYSIOLOGICALLY ACTIVE SUBSTANCE OR SALT THEREOF, AND METHOD FOR PRODUCING SAME

IPC classification:
C07K 1/06, A61K 39/00, A61K 47/26, A61K 47/36, A61K 47/48
Agent:
Christian Heubeck, Weickmann & Weickmann PartmbB
Status:
GRANT OF PATENT INTENDED
EP15162381

AXL ANTIBODIES

IPC classification:
A61P 35/00, C07K 16/28, C12N 15/13, A61K 31/282, A61K 31/704, A61K 39/395
Agent:
Christian Heubeck, Weickmann & Weickmann PartmbB
Status:
EXAMINATION IN PROGRESS
EP12739597

INDOLE DERIVATIVE, AND PHARMACOLOGICALLY ACCEPTABLE SALT THEREOF

IPC classification:
A61P 13/02, A61P 13/10, A61P 43/00, C07D 209/08, C07D 401/06, C07D 401/14, C07D 405/06, C07D 405/14, C07D 409/14, C07D 413/14, C07D 417/14, A61K 31/404, A61K 31/4439, A61K 31/444, A61K 45/00
Agent:
Christian Heubeck, Weickmann & Weickmann PartmbB
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13863709

RECOMBINANT PROTEIN

IPC classification:
A61P 7/06, C07K 14/505, C07K 19/00, C12N 5/10, C12N 15/62, A61K 38/18
Agent:
Christian Heubeck, Weickmann & Weickmann PartmbB
Status:
EXAMINATION IN PROGRESS
EP15170809

IMMUNOGENIC COMPOSITION AND USES THEREOF

IPC classification:
A61P 37/04, A61K 31/13, A61K 31/23, A61K 38/03, A61K 38/38, A61K 39/00
Applicant:
University of Melbourne
Agent:
Christian Heubeck, Weickmann & Weickmann PartmbB
Status:
The patent has been granted
EP14751813

METHOD FOR PRODUCING A PLURALITY OF TEETH FROM ONE ISOLATED TOOTH GERM

IPC classification:
C12N 5/073, A61K 6/02, A61L 27/00
Agent:
Christian Heubeck, Weickmann & Weickmann PartmbB
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP14706543

CAIX STRATIFICATION BASED CANCER TREATMENT

IPC classification:
A61P 35/00, A61K 39/395
Agent:
Christian Heubeck, Weickmann & Weickmann PartmbB
Status:
EXAMINATION IN PROGRESS
EP14773826

HETEROCYCLIC COMPOUND

IPC classification:
A61P 1/04, A61P 17/00, A61P 17/06, A61P 19/08, A61P 25/00, A61P 29/00, A61P 37/02, A61P 37/06, A61P 43/00, C07D 471/04, C07D 519/00, A61K 31/437, A61K 31/438, A61K 31/4545, A61K 31/496, A61K 31/4985, A61K 31/5377, A61K 31/541, A61K 31/553
Applicant:
Takeda Pharmaceutical Company Limited
Agent:
Christian Heubeck, Weickmann & Weickmann PartmbB
Status:
EXAMINATION IN PROGRESS
EP15181215

RECEPTORS OF RSPO2 AND RSPO3

IPC classification:
G01N 33/50, G01N 33/68, A61K 39/00
Applicant:
Deutsches Krebsforschungszentrum (DKFZ)
Agent:
Christian Heubeck, Weickmann & Weickmann PartmbB
Status:
EXAMINATION REQUESTED
EP14720964

METHOD OF DIAGNOSING CANCER

IPC classification:
G01N 33/574
Applicant:
Apogenix GmbH
Applicant:
Apogenix AG
Agent:
Christian Heubeck, Weickmann & Weickmann PartmbB
Status:
EXAMINATION IN PROGRESS
EP15190671

RSPONDINS AS MODULATORS OF ANGIOGENESIS AND VASCULOGENESIS

IPC classification:
A61P 35/00, A61K 38/17
Applicant:
Deutsches Krebsforschungszentrum (DKFZ)
Agent:
Vossius & Partner Patentanwälte Rechtsanwälte mbB
Agent:
Christian Heubeck, Weickmann & Weickmann PartmbB
Status:
GRANT OF PATENT INTENDED
EP14820598

METAL FOIL FOR ELECTROMAGNETIC SHIELDING, ELECTROMAGNETIC SHIELDING MEMBER, AND SHIELDED CABLE

IPC classification:
B32B 15/08, C23C 30/00, C25D 5/10, C25D 5/50, C25D 7/06, H01B 5/02, H01B 5/14, H01B 7/17, H05K 9/00
Applicant:
JX Nippon Mining & Metals Corporation
Agent:
Christian Heubeck, Weickmann & Weickmann PartmbB
Status:
GRANT OF PATENT INTENDED
EP14814295

MEDICINAL COMPOSITION FOR PROMOTING SYNTHESIS OF PROTOPORPHYRIN IX

IPC classification:
A61P 31/04, A61P 43/00, A61K 31/19, A61K 31/194, A61K 31/198, A61K 31/375, A61K 33/40, A61K 41/00, A61K 45/00
Applicant:
Osaka City University
Applicant:
SBI Pharmaceuticals Co Ltd
Agent:
Christian Heubeck, Weickmann & Weickmann PartmbB
Status:
GRANT OF PATENT INTENDED
EP14820189

ELECTROMAGNETIC WAVE SHIELD-USE METAL FOIL, ELECTROMAGNETIC WAVE SHIELD MATERIAL AND SHIELD CABLE

IPC classification:
B32B 9/00, C22C 13/00, C22C 19/03, C23C 8/12, C23C 14/06, C23C 28/00, C25D 5/12, C25D 5/50, H01B 7/17, H05K 9/00
Applicant:
JX Nippon Mining & Metals Corporation
Agent:
Christian Heubeck, Weickmann & Weickmann PartmbB
Status:
GRANT OF PATENT INTENDED
EP11752253

NOVEL OLEFIN METATHESIS CATALYSTS

IPC classification:
B01J 31/22, B01J 31/16, B01J 31/18, C07F 15/00
Applicant:
Bergen Teknologioverføring AS
Agent:
Christian Heubeck, Weickmann & Weickmann PartmbB
Status:
PATENT GRANTED
EP14854505

DELIVERY METHODS AND COMPOSITIONS FOR NUCLEASE-MEDIATED GENOME ENGINEERING

IPC classification:
C12N 15/64, C12N 15/85
Applicant:
Sangamo BioSciences, Inc.
Agent:
Christian Heubeck, Weickmann & Weickmann PartmbB
Status:
GRANT OF PATENT INTENDED
EP16150412

TNF SUPERFAMILY COLLECTIN FUSION PROTEINS

IPC classification:
C07K 14/42, C07K 14/47, C07K 14/525, C12N 5/10, C12N 15/28, C12N 15/62, A61K 38/19
Applicant:
Apogenix AG
Agent:
Christian Heubeck, Weickmann & Weickmann PartmbB
Status:
The patent has been granted
EP15161647

DIAGNOSIS AND TREATMENT OF LOW GRADE GLIOMAS

IPC classification:
G01N 33/574
Applicant:
Ludwig-Maximilians-Universität München
Applicant:
Deutsches Krebsforschungszentrum (DKFZ)
Agent:
Christian Heubeck, Weickmann & Weickmann PartmbB
Status:
APPLICATION REFUSED
EP15168152

COMBINATION OF FGFR4-INHIBITOR AND BILE ACID SEQUESTRANT

IPC classification:
A61P 3/04, A61P 3/10, A61P 9/00, A61P 9/12, A61P 13/12, A61P 21/00, A61P 35/00, A61K 31/7088, A61K 31/785, A61K 31/787, A61K 38/02, A61K 38/16, A61K 39/00, A61K 39/395, A61K 45/06
Applicant:
Daiichi Sankyo Company, Limited (Daiichi Sankyō Kabushiki-kaisha)
Agent:
Christian Heubeck, Weickmann & Weickmann PartmbB
Status:
EXAMINATION REQUESTED
EP15176276

IMPROVED OLEFIN METATHESIS CATALYSTS

IPC classification:
C07F 15/00
Agent:
Christian Heubeck, Weickmann & Weickmann PartmbB
Status:
APPLICATION WITHDRAWN

Please Sign in to use this feature